google-play

Scan to Download iOS&Android APP

Trade Cardinal Health - CAH CFD

66.11
0.72%
0.22
Low: 65.51
High: 67.14
Market Trading Hours* (UTC) Opens on Wednesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading Conditions
Long position overnight fee -0.0308%
Short position overnight fee -0.0137%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Cardinal Health Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 65.64
Open* 66.13
1-Year Change* 29.29%
Day's Range* 65.51 - 65.51
52 wk Range 45.85-72.28
Average Volume (10 days) 3.37917
Average Volume (3 months) 57.0802
Market Cap 17923.1
P/E Ratio N/A
Shares Outstanding 272512000
Revenue 181364
EPS -3.44059
Dividend (Yield %) 3.01475
Beta 0.79069
Next Earnings Date Nov 4, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 27, 2022 66.11 0.31 0.47% 65.80 67.24 65.42
Sep 26, 2022 65.64 0.32 0.49% 65.32 66.40 65.32
Sep 23, 2022 65.96 -0.59 -0.89% 66.55 66.84 64.89
Sep 22, 2022 67.15 0.00 0.00% 67.15 67.69 66.57
Sep 21, 2022 67.41 -1.09 -1.59% 68.50 69.15 67.41
Sep 20, 2022 67.67 -0.02 -0.03% 67.69 68.19 67.18
Sep 19, 2022 68.11 2.06 3.12% 66.05 68.15 66.03
Sep 16, 2022 66.74 0.76 1.15% 65.98 66.92 65.55
Sep 15, 2022 66.29 -0.44 -0.66% 66.73 67.19 66.16
Sep 14, 2022 66.64 0.02 0.03% 66.62 67.29 66.02
Sep 13, 2022 66.73 -1.32 -1.94% 68.05 68.51 66.56
Sep 12, 2022 68.94 -0.71 -1.02% 69.65 70.02 68.74
Sep 9, 2022 69.79 -0.78 -1.11% 70.57 70.72 69.78
Sep 8, 2022 70.53 0.14 0.20% 70.39 71.11 69.58
Sep 7, 2022 70.86 1.62 2.34% 69.24 71.00 68.89
Sep 6, 2022 69.36 -1.58 -2.23% 70.94 71.31 68.63
Sep 2, 2022 70.89 -0.51 -0.71% 71.40 72.20 70.67
Sep 1, 2022 71.21 0.46 0.65% 70.75 71.34 70.20
Aug 31, 2022 70.62 0.83 1.19% 69.79 70.78 69.58
Aug 30, 2022 69.73 0.12 0.17% 69.61 70.35 69.10

Cardinal Health Events

 (UTC)
Friday, November 4, 2022
12:00
  US
Cardinal Health Inc Annual Shareholders Meeting
Monday, November 7, 2022
13:30
  US
Q1 2023 Cardinal Health Inc Earnings Release
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 121546 129976 136809 145534 152922 162467
Revenue 121546 129976 136809 145534 152922 162467
Cost of Revenue, Total 115003 123432 129628 138700 146054 155689
Gross Profit 6543 6544 7181 6834 6868 6778
Total Operating Expense 119087 127856 136685 143474 157036 162009
Selling/General/Admin. Expenses, Total 3648 3775 4596 4480 4572 4533
Depreciation / Amortization 355 392 574 531 512 428
Unusual Expense (Income) 81 257 1887 -237 5898 1359
Operating Income 2459 2120 124 2060 -4114 458
Interest Income (Expense), Net Non-Operating -195 -206 -334 -307 341 -182
Other, Net 12 10 -18 -2 1 47
Net Income Before Taxes 2276 1924 -228 1751 -3772 323
Net Income After Taxes 1431 1294 -677 1365 -3693 612
Minority Interest -4 -6 -3 -2 -3 -1
Net Income Before Extra. Items 1427 1288 -680 1363 -3696 611
Total Extraordinary Items 0 0 936
Net Income 1427 1288 256 1363 -3696 611
Income Available to Common Excl. Extra. Items 1427 1288 -680 1363 -3696 611
Income Available to Common Incl. Extra. Items 1427 1288 256 1363 -3696 611
Dilution Adjustment 0
Diluted Net Income 1427 1288 256 1363 -3696 611
Diluted Weighted Average Shares 330 320 313 301 293 294
Diluted EPS Excluding Extraordinary Items 4.32424 4.025 -2.17252 4.52824 -12.6143 2.07823
Dividends per Share - Common Stock Primary Issue 1.548 1.7956 1.8496 1.9052 1.9244 1.9436
Diluted Normalized EPS 4.47857 4.56515 1.74617 3.91444 0.65853 5.02092
Q3 2021 Q4 2021 Q1 2021 Q2 2021 Q3 2022
Total revenue 39275 42586 43968 45457 44836
Revenue 39275 42586 43968 45457 44836
Cost of Revenue, Total 37463 41111 42326 43841 43154
Gross Profit 1812 1475 1642 1616 1682
Total Operating Expense 38802 42437 43563 46407 44933
Selling/General/Admin. Expenses, Total 1120 1129 1114 1151 1137
Depreciation / Amortization 109 91 78 79 78
Unusual Expense (Income) 110 106 45 1336 564
Operating Income 473 149 405 -950 -97
Interest Income (Expense), Net Non-Operating -45 -46 -40 -36 -37
Other, Net 12 16 4 13 -3
Net Income Before Taxes 440 119 369 -973 -137
Net Income After Taxes 120 115 272 49 -1390
Minority Interest -1 1 -1 0 -1
Net Income Before Extra. Items 119 116 271 49 -1391
Net Income 119 116 271 49 -1391
Income Available to Common Excl. Extra. Items 119 116 271 49 -1391
Income Available to Common Incl. Extra. Items 119 116 271 49 -1391
Diluted Net Income 119 116 271 49 -1391
Diluted Weighted Average Shares 294 294 289 281 275
Diluted EPS Excluding Extraordinary Items 0.40476 0.39456 0.93772 0.17438 -5.05818
Dividends per Share - Common Stock Primary Issue 0.4859 0.4859 0.4908 0.4908 0.4908
Diluted Normalized EPS 0.64575 0.66081 1.05249 3.26708 -3.72509
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 21956 28345 24553 25747 25940 31048
Cash and Short Term Investments 2356 6879 1763 2531 2771 3407
Cash & Equivalents 2356 6879 1763 2531 2771 3407
Total Receivables, Net 7405 8048 7800 8448 8264 9103
Accounts Receivable - Trade, Net 7405 8048 7800 8448 8264 9103
Total Inventory 10615 11301 12308 12822 13198 14594
Prepaid Expenses 1578 2114 1921 1940 1707 2843
Other Current Assets, Total 2 3 761 6 1101
Total Assets 34122 40112 39951 40963 40766 44453
Property/Plant/Equipment, Total - Net 1796 1879 2487 2356 2792 2820
Property/Plant/Equipment, Total - Gross 4476 4627 5260 5168 5757 6048
Accumulated Depreciation, Total -2680 -2748 -2773 -2812 -2965 -3228
Goodwill, Net 7167 7221 8316 8378 8357 7989
Intangibles, Net 2259 1986 3913 3430 2918 2105
Other Long Term Assets, Total 944 681 682 1052 759 491
Total Current Liabilities 19701 21221 22893 24109 23615 27624
Accounts Payable 17306 17906 19677 21535 21374 23700
Accrued Expenses 1803 1983 1999 2117 2231 2957
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 587 1327 1001 452 10 871
Other Current Liabilities, Total 5 5 216 5 96
Total Liabilities 27568 33304 33892 34635 38977 42662
Total Long Term Debt 4952 9068 8012 7579 6765 5365
Long Term Debt 4952 9068 8012 7579 6740 5320
Deferred Income Tax 2770 2858 2975 2945 8253 9296
Minority Interest 134 138 12 2 3 3
Other Liabilities, Total 11 19 341 374
Total Equity 6554 6808 6059 6328 1789 1791
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 3010 2697 2730 2763 2789 2806
Retained Earnings (Accumulated Deficit) 6419 4967 4645 5434 1170 1205
Treasury Stock - Common -2759 -731 -1224 -1790 -2066 -2186
Other Equity, Total -116 -125 -92 -79 -104 -34
Total Liabilities & Shareholders’ Equity 34122 40112 39951 40963 40766 44453
Total Common Shares Outstanding 322 316 309 299 293 291
Capital Lease Obligations 25 45
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 30362 31048 29731 31847 30884
Cash and Short Term Investments 3499 3407 2463 3161 2356
Cash & Equivalents 3499 3407 2463 3161 2356
Total Receivables, Net 8727 9103 9305 9406 10250
Accounts Receivable - Trade, Net 8727 9103 9305 9406 10250
Total Inventory 14329 14594 14720 14941 15493
Prepaid Expenses 2715 2843 3243 4339 2785
Other Current Assets, Total 1092 1101 0 0 0
Total Assets 43874 44453 42993 43680 42111
Property/Plant/Equipment, Total - Net 2315 2820 2336 2321 2298
Goodwill, Net 7986 7989 7979 6656 6167
Intangibles, Net 2193 2105 2026 1943 1855
Other Long Term Assets, Total 1018 491 921 913 907
Total Current Liabilities 25323 27624 26499 27729 28715
Accounts Payable 22641 23700 23408 24759 24821
Accrued Expenses 2573 2957 2790 2669 3033
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 16 871 301 301 861
Other Current Liabilities, Total 93 96 0 0 0
Total Liabilities 42084 42662 41600 42682 42808
Total Long Term Debt 6715 5365 5353 5342 4751
Long Term Debt 6715 5320 5353 5342 4751
Deferred Income Tax 10042 9296 9745 9607 9338
Minority Interest 4 3 3 4 4
Total Equity 1790 1791 1393 998 -697
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2807 2806 2666 2721 2761
Retained Earnings (Accumulated Deficit) 1233 1205 1335 1245 -281
Treasury Stock - Common -2202 -2186 -2547 -2883 -3100
Other Equity, Total -48 -34 -61 -85 -77
Total Liabilities & Shareholders’ Equity 43874 44453 42993 43680 42111
Total Common Shares Outstanding 291 291 284 277 273
Capital Lease Obligations 45
Other Liabilities, Total 374
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 1431 1294 259 1365 -3693 612
Cash From Operating Activities 2971 1184 2764 2722 1960 2320
Cash From Operating Activities 641 717 1032 1000 913 783
Deferred Taxes 87 291 -1012 -83 -961 496
Non-Cash Items 189 176 1619 -315 -360 140
Cash Taxes Paid 635 686 425 311 368 273
Cash Interest Paid 174 200 320 285 226 182
Changes in Working Capital 623 -1294 866 755 6061 289
Cash From Investing Activities -4080 -405 -5608 338 493 -378
Capital Expenditures -465 -387 -384 -328 -375 -400
Other Investing Cash Flow Items, Total -3615 -18 -5224 666 868 22
Cash From Financing Activities -1139 3746 -2276 -2293 -2200 -1317
Financing Cash Flow Items 4 59 -144 -14 120 26
Total Cash Dividends Paid -512 -577 -581 -577 -569 -573
Issuance (Retirement) of Stock, Net -651 -600 -550 -600 -350 -200
Issuance (Retirement) of Debt, Net 20 4864 -1001 -1102 -1401 -570
Foreign Exchange Effects -12 -2 4 1 -13 11
Net Change in Cash -2260 4523 -5116 768 240 636
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 497 612 272 321 -1069
Cash From Operating Activities 1678 2320 -537 658 239
Cash From Operating Activities 603 783 168 332 513
Non-Cash Items 126 140 153 1478 1883
Changes in Working Capital 452 289 -1130 -1473 -1088
Cash From Investing Activities -290 -378 862 815 771
Capital Expenditures -274 -400 -67 -141 -223
Other Investing Cash Flow Items, Total -16 22 929 956 994
Cash From Financing Activities -668 -1317 -1264 -1708 -2048
Financing Cash Flow Items 17 26 -28 -27 -26
Total Cash Dividends Paid -432 -573 -149 -289 -425
Issuance (Retirement) of Stock, Net -200 -200 -500 -800 -1000
Issuance (Retirement) of Debt, Net -53 -570 -587 -592 -597
Foreign Exchange Effects 8 11 -5 -11 -13
Net Change in Cash 728 636 -944 -246 -1051
Deferred Taxes 496

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
450000+

Traders

76000+

Active clients monthly

$54000000+

Monthly investing volume

$29000000+

Withdrawn each month

CFD Trading calculator

Calculate your hypothetical P&L if you had opened a trade today #current date# at the market opening price:

Market
  • Cardinal Health
Investment
Position size 100
Leverage
Opening price
Current price
Spread
Trade commission 0
Past performance is not a reliable indicator of future results
Profit/Loss

Cardinal Health Company profile

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Financial summary

BRIEF: For the six months ended 31 December 2021, Cardinal Health Inc revenues increased 11% to $89.43B. Net income decreased 15% to $320M. Revenues reflect Pharmaceutical segment increase of 12% to $81.2B, United States segment increase of 11% to $87.22B. Net income was offset by Medical segment income decrease of 63% to $173M, Corporate segment loss increase of 7% to $1.54B. Dividend per share increased from $0.97 to $1.47.

Equity composition

Common no Par, 3/11, 755M auth., 363,600,000 issd., less 13,300,000 in Treas. @ $487.2M. Insiders & Strategic holders own 0.10%. IPO:9/94, 7M shs @ $39 by Smith Barney. *FY'97 -'99 fncls & '98-'99 Q rest'd for merger with Scherer(8/98),llegiance (3/99), PSI(5/99), & ALP (9/99).

Industry: Drug Retailers (NEC)

7000 Cardinal Pl
DUBLIN
OHIO 43017
US

Income statement

People Also Watch

US100

11,130.70 Price
-1.420% 1D Chg, %
Long position overnight fee -0.0142%
Short position overnight fee 0.0042%
Overnight fee time 21:00 (UTC)
Spread 1.5

XRP/USD

0.42 Price
-5.290% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 21:00 (UTC)
Spread 0.00600

Oil - Crude

77.99 Price
+0.100% 1D Chg, %
Long position overnight fee 0.0141%
Short position overnight fee -0.0313%
Overnight fee time 21:00 (UTC)
Spread 0.03

Natural Gas

6.89 Price
+1.290% 1D Chg, %
Long position overnight fee -0.0559%
Short position overnight fee 0.0335%
Overnight fee time 21:00 (UTC)
Spread 0.005

Still looking for a broker you can trust?

Join the 450.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading